What's new

EMEA-003623-PIP01-24

EMEA-003623-PIP01-24

Jun 11, 2025 - 15:05
 0
EMEA-003623-PIP01-24
EMEA-003623-PIP01-24
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, de...

Next Article

EMEA-003624-PIP01-24

Related Posts

EMEA-003540-PIP01-23

EMEA-003540-PIP01-23

Jun 6, 2025  0

Minutes of the CHMP meeting 9-12 December 2024

May 27, 2025  0

Nitrosamine impurities: guidance for marketing authorisation holders

Nitrosamine impurities: guidance for marketing authoris...

May 28, 2025  0